PropThink: Previewing Gilead's 'Quad' Ahead of FDA Decision
Research - On August 27th the FDA is set to decide on whether to approve Gilead Science’s (NASDA:GILD) pending HIV treatment, the Quad. Â If approved, the Quad … Continue Reading
Read nowMust Read
Obesity & PD-1: History Doesn’t Repeat But It Rhymes
The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical Submits 510(k) for Insulin Patch Pump
Modular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLatest Posts
Spectrum Publicly Denying Fusilev’s Price Was Cut; Stock Likely To Bounce
Long Ideas - Spectrum Pharmaceuticals (NASDAQ:SPPI) is defending its Fusilev cancer treatment franchise after a recent article suggested that pricing for the drug had been cut. An article … Continue Reading
Read nowAegis’ Buy Rating on Rosetta Genomics May Not Be As Independent As One Might Like
- Rosetta Genomics (NASDAQ:ROSG) gapped up 17% in early trading today after Aegis Capital initiated a Buy rating on the company with a target price of … Continue Reading
Read nowPrana Volume Up on Phase II Trial Updates for Its PBT2 Alzheimer's Candidate
Long Ideas - Australian-listed Prana Biotechnology (ASX:PBT)(NASDAQ:PRAN) gave updates today on the company’s ongoing Phase II trials for lead compound PBT2, a potential treatment for neurodegenerative diseases Alzheimer’s … Continue Reading
Read nowJefferies Initiates "Buy" On PROLOR Biotech
Long Ideas - Shares of PROLOR Biotech (NYSEAMEX:PBTH) are trading up this morning after Jefferies initiated a “Buy” rating with an $8 price target. The company develops a … Continue Reading
Read nowNew Intermezzo Patent And Orange Book Listing Are Major Positives For Transcept Pharma
Long Ideas - Transcept Pharmaceuticals (NASDAQ:TSPT) announced after the close yesterday that its newly issued patent (U.S. Patent No. 8,242,131, or the ‘131 patent) was posted in the … Continue Reading
Read nowAlexza Gains on GMP Certification May Not Last Through Trading Session
Short Ideas - Alexza Pharmaceuticals (NASDAQ:ALXA) reported this morning that the company’s Adasuve manufacturing facility in Mountain View, CA received a Certificate of GMP (Good Manufacturing Practice) Compliance … Continue Reading
Read now